Table 1. Sex and age information of neurodegenerative disease patients and controls.
| Neurodegenerative diseases | Sex (male/female) | Age (years)1 | ||||
| Case | Control | P2 | Case | Control | P3 | |
| Alzheimer's Disease | ||||||
| Entorhinal Cortex | 4/6 | 10/3 | 0.102 | 85.6 ± 6.3 | 80.3 ± 9.2 | 0.118 |
| Hippocampus | 6/4 | 10/3 | 0.650 | 77.8 ± 5.7 | 79.6 ± 9.4 | 0.574 |
| Medial Temporal Gyrus | 10/6 | 8/4 | 1.000 | 79.1 ± 6.4 | 80.1 ± 9.8 | 0.771 |
| Posterior Cingulate | 6/3 | 9/4 | 1.000 | 77.6 ± 6.5 | 79.8 ± 9.4 | 0.522 |
| Superior Frontal Gyrus | 13/10 | 7/4 | 1.000 | 79.2 ± 7.5 | 79.3 ± 10.2 | 0.977 |
| Primary Visual Cortex | 11/8 | 9/3 | 0.452 | 80.2 ± 6.7 | 77.9 ± 6.9 | 0.385 |
| Parkinson's Disease | ||||||
| Prefrontal Cortex | 8/6 | 10/5 | 0.710 | 77.0 ± 6.3 | 71.2 ± 11.1 | 0.095 |
| Putamen | 9/6 | 15/5 | 0.467 | 76.7 ± 6.2 | 66.4 ± 13.8 | 0.006 |
| Substantia Nigra | 6/5 | 13/5 | 0.432 | 75.5 ± 5.8 | 66.8 ± 14.4 | 0.033 |
| Huntington's Disease | ||||||
| Caudate Nucleus | 23/15 | 23/9 | 0.449 | 59.0 ± 14.9 | 58.4 ± 18.1 | 0.877 |
| Frontal Cortex | 22/15 | 19/9 | 0.606 | 56.6 ± 15.5 | 56.1 ± 17.5 | 0.914 |
| Cerebellum | 23/16 | 16/11 | 1.000 | 58.3 ± 15.6 | 59.1 ± 17.5 | 0.849 |
1 Data are presented as the mean ± standard deviation.
2 Fisher's exact test was used to compare population sex in the two groups.
3 Welch two sample t-test was used to compare population age in the two groups.